Company Filing History:
1 out of 117 
1 out of 361 
Years Active: 2015-2017
Title: Shuyi Si: Innovator in Lipid Metabolism Regulation
Introduction
Shuyi Si is a prominent inventor based in Beijing, China. He has made significant contributions to the field of lipid metabolism through his innovative research and patents. With a total of 2 patents, his work focuses on the use of microRNA and its inhibitors in regulating lipid metabolism.
Latest Patents
One of Shuyi Si's latest patents is titled "Use of MicroRNA or inhibitors thereof in regulation of lipid metabolism." This invention relates to the use of specific microRNAs, such as miRNA-96, miRNA-185, and miRNA-223, in preparing medicaments for regulating lipid metabolism. The invention aims to prevent or treat diseases related to lipid metabolism, including hyperlipidemia and coronary heart disease. Another notable patent is "Na/K-ATPase ligands, ouabain antagonists, assays and uses thereof." This patent describes methods for inhibiting ATPase activity without stimulating receptor function, which can be crucial for heart health.
Career Highlights
Shuyi Si has worked with esteemed institutions such as the Chinese Academy of Medical Sciences and the University of Toledo. His research has garnered attention for its potential applications in medical treatments and therapies.
Collaborations
Shuyi has collaborated with notable colleagues, including Bin Hong and Li Wang, who have contributed to his research endeavors.
Conclusion
Shuyi Si's innovative work in lipid metabolism regulation showcases his dedication to advancing medical science. His patents reflect a commitment to developing effective treatments for diseases related to lipid metabolism.